Bio Medica Laboratories Limited
Bookbuilding IPO · NSE
- Price band
- ₹132 - ₹139
- Lot size
- 1,000 shares
- Issue amount
- ₹52.43 cr
- Total subscription
- 2.31×
- Opens
- 21 May 2026
- Closes
- 25 May 2026
- Allotment
- 26 May 2026
- Listing
- 29 May 2026
Offer at a glance
Issue overview
- Issue size
- 37,72,000 shares
- Face value
- ₹10 per share
- Minimum investment
- ₹1,32,000
- Fresh issue
- ₹47.19 cr
- Offer for sale
- ₹5.24 cr
- Registrar
- Skyline Financial Services Private Limited
- Listing exchange
- NSE
- Maximum investment
- ₹1,39,000
- Issue type
- Bookbuilding IPO
- Shares before issue
- 91,80,001
- Shares after issue
- 1,25,75,001
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail | 2 | 2,000 | ₹2,78,000 |
| sHNI | 3 | 3,000 | ₹4,17,000 |
| bHNI | 8 | 8,000 | ₹11,12,000 |
Share reservation
Subscription & GMP
Subscription by category
Reported 25 May 2026
GMP history
Day-wise demand
Application-wise demand
| Category | Reserved applications | Applied applications |
|---|---|---|
| QIB | 0 | 6 |
| NIB | 0 | 457 |
| RETAIL | 896 | 2,614 |
| HNIs(10L +) | 390 | 35 |
| HNIs (2-10L) | 195 | 422 |
Subscription demand
Amounts in ₹ crore. HNI subcategories are included in the NII total.
| Category | Offered | Demand |
|---|---|---|
| QIBs | 0.5 | 7.98 |
| FIIs | 0 | 7.98 |
| RETAIL | 24.91 | 72.67 |
| HNIs 2+ | 8.13 | 17.82 |
| HNIs 10+ | 16.26 | 16.58 |
Financial performance
Company financials
In Crores · Reported periods may include interim results.
Key performance indicators
| Metric | Nov-25 | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|---|
| EPS | 9.44 | 10.67 | 2.72 | 0.36 |
| ROE | 54.41 | 99.59 | 67.74 | 13.92 |
| ROCE | 23.24 | 48.2 | 29.92 | 10.16 |
| RONW | 0 | 0 | 0 | 0 |
| PRE IPO(PE) | 0 | 13.03 | 0 | 0 |
| POST IPO(PE) | 13.45 | 0 | 0 | 0 |
Values and labels as reported in the issue data.
Peer comparison
| Company | P/E(X) | CMP* (₹) | Face value (₹) | NAV/Share (₹) | RONW(%) | EPS (Basic) (₹) |
|---|---|---|---|---|---|---|
| Bio Medica Laboratories Limited | 0 | 0 | 10.00 | 16.05 | 99.59 | 10.67 |
| Zenotech Laboratories Limited | 0 | 47.95 | 10.00 | 15.76 | 6.01 | 0.92 |
| Shukra Pharmaceuticals Limited | 47.57 | 33.54 | 1.00 | 1.43 | 15.90 | 0.22 |
Company information
Company profile
Bio Medica Laboratories is a pharmaceutical company engaged in manufacturing parenteral formulations for both human and veterinary healthcare segments. The company produces a wide range of ethical drugs, generic medicines, and OTC products, primarily in liquid and dry powder injectable forms. Its portfolio includes 58 liquid injectables and 15 dry powder injectable products available in single-dose and multi-dose formats. Operating on a B2B contract manufacturing model, the company develops customized formulations according to client requirements. Supported by GMP and GLP certifications, Bio Medica runs two manufacturing facilities in Indore, Madhya Pradesh, focusing on quality production and pharmaceutical formulation development.
Strengths
- Diversified Injectable Portfolio: Offers a wide range of liquid and dry powder injectables for various therapeutic needs.
- Strong Contract Manufacturing: B2B-focused model supports customized formulation development for pharmaceutical clients.
- Experienced Management & Workforce: Industry-experienced teams support efficient manufacturing and quality standards.
Risk factors
- Regulatory Compliance Risk: Previous suspension of operations at a manufacturing unit due to non-compliance may affect reputation and business operations.
- Customer Concentration Risk: Dependence on a limited number of clients may impact financial performance if key customers are lost.
- Quality Control & Manufacturing Risk: Product defects or quality issues may lead to litigation, regulatory action, and reputational damage.
Promoters
Mr. Mukesh Mehta
Mr. Pradeep Mehta
Registrar & documents
Lead manager
Narnolia Financial Services Limited
Registrar & contacts
Skyline Financial Services Private Limited
[email protected]Official registrar portal ↗IPO allotment status guide →Registered office
Plot No. 11B-11C, Sector-E, Sanwer Road Industrial Area, Industrial Estate (Indore), Indore, Madhya Pradesh, 452015
+91 7314102751
[email protected]Company website ↗Understanding BMLL IPO data
Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.